Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... Read More
U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07757802) titled 'Phase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy Adults' on Ju... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safet... Read More
U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07756853) titled 'Visual Attention, Object Recognition, and Eye Movements in Healthy Volunteers' on Aug. 08. ... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) M... Read More
U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07758777) titled 'Usability Evaluation of the Intelligent Fingerprinting Drug Screening System' on July 30. ... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig i... Read More
U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07758387) titled 'Polydextrose Functional Gummies for Weight Management in Adults With Overweight or Obesity'... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and ... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of ascim... Read More